Next-generation sequencing ofCOL4A3, COL4A4, andCOL4A5 before tissue biopsy would be reasonable when suspicion of Alport syndrome is high, e.g. when the patient is a male with hematuria who has an extensive family history of hematuria, deafness, and ESRD. Here, COL4A4 is linked to Alport syndrome.